Sustained blood pressure reduction associated with percutaneous auricular vagus nerve stimulation in hypertensive chronic pain patients: a retrospective dual-center analysis
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background Hypertension is a major risk factor for cardiovascular diseases, affecting over 1.28 billion adults worldwide, with nearly 46% remaining undiagnosed or untreated. Auricular vagus nerve stimulation (aVNS) has emerged as a promising non-invasive neuromodulation approach for autonomic regulation, yet its effects on blood pressure (BP) remain underexplored. Objective The effects of aVNS on blood pressure in chronic pain patients were evaluated, with a specific focus on differential responses by hypertensive status and antihypertensive treatment. Methods This retrospective dual-center study analyzed the impact of aVNS on BP in 24 chronic pain patients [mean age 48.5 (9.1) years; 75% female], categorized into non-hypertensive ( n = 13) and hypertensive ( n = 11) individuals. The hypertensive cohort was further stratified into patients receiving pharmacological hypertension treatment ( n = 5) and those untreated ( n = 6). Patients received aVNS over an 8-week treatment period, followed by a 4-week follow-up. Results Over an 8-week treatment period, hypertensive patients exhibited significant reductions in systolic BP [−10.7 (2.9) mmHg, p = 0.0003] and diastolic BP [−5.8 (2.0) mmHg, p = 0.0357], while non-hypertensive individuals showed no significant BP changes. Subgroup analysis revealed that BP reductions were most robust and consistent in untreated hypertensive patients (SBP: −11.0 mmHg, p = 0.001), whereas patients on antihypertensive medication showed greater variability. Mean arterial pressure (MAP) declined significantly in hypertensive individuals [−9.3 (6.7) mmHg, p = 0.0022]. In contrast, no significant changes were observed in heart rate or heart rate variability [e.g., heart rate: −0.9 (1.8) beats/min; root mean square of successive differences in normal RR intervals: −12.8 (9.0) ms at week 12, both p = 1.0000], suggesting preserved autonomic stability. Conclusions aVNS may be associated with BP reductions in hypertensive patients particularly those not receiving pharmacological treatment, with minimal effects in normotensive individuals. These retrospective findings suggest a potential sustained benefit in patients with comorbid chronic pain and support further investigation through prospective, sham-controlled trials to confirm efficacy and clarify underlying mechanisms.
Fields of Study & Subjects
Vagus Nerve Stimulation Research
Blood Pressure and Hypertension Studies
Heart Rate Variability and Autonomic Control
Publication details
- Journal / source
- Frontiers in Cardiovascular Medicine
- Volume
- 13
- Pages
- 1736774–1736774
- Publication date
- 30 March 2026
- Language
- EN